High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.
Hiddemann
W
W
Department of Hematology, University of Münster, Germany.
Aul
C
C
Maschmeyer
G
G
Schönrock-Nabulsi
R
R
Ludwig
W D
WD
Bartholomäus
A
A
Bettelheim
P
P
Becker
K
K
Balleisen
L
L
Lathan
B
B
D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D011446:Prospective Studies; D012008:Recurrence
D003561:Cytarabine; D008942:Mitoxantrone